430 related articles for article (PubMed ID: 9802988)
1. Two new p73 splice variants, gamma and delta, with different transcriptional activity.
De Laurenzi V; Costanzo A; Barcaroli D; Terrinoni A; Falco M; Annicchiarico-Petruzzelli M; Levrero M; Melino G
J Exp Med; 1998 Nov; 188(9):1763-8. PubMed ID: 9802988
[TBL] [Abstract][Full Text] [Related]
2. p73gamma transactivates the p21 promoter through preferential interaction with the p300/CBP-associated factor in human prostate cancer cells.
Momii Y; Izumi H; Shiota M; Onitsuka T; Abe T; Kobayashi H; Miyamoto N; Uchiumi T; Kohno K
Oncol Rep; 2007 Aug; 18(2):411-6. PubMed ID: 17611664
[TBL] [Abstract][Full Text] [Related]
3. New p73 variants with altered C-terminal structures have varied transcriptional activities.
Ueda Y; Hijikata M; Takagi S; Chiba T; Shimotohno K
Oncogene; 1999 Sep; 18(35):4993-8. PubMed ID: 10490834
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the wild type p73 gene in breast cancer tissues and cell lines.
Zaika AI; Kovalev S; Marchenko ND; Moll UM
Cancer Res; 1999 Jul; 59(13):3257-63. PubMed ID: 10397274
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated transfer of p53-related genes induces apoptosis of human cancer cells.
Ishida S; Yamashita T; Nakaya U; Tokino T
Jpn J Cancer Res; 2000 Feb; 91(2):174-80. PubMed ID: 10761704
[TBL] [Abstract][Full Text] [Related]
6. p73 independent of c-Myc represses transcription of platelet-derived growth factor beta-receptor through interaction with NF-Y.
Hackzell A; Uramoto H; Izumi H; Kohno K; Funa K
J Biol Chem; 2002 Oct; 277(42):39769-76. PubMed ID: 12167641
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of naturally occurring mutants (P405R and P425L) of p73alpha and p73beta found in neuroblastoma and lung cancer.
Naka M; Ozaki T; Takada N; Takahashi M; Shishikura T; Sakiyama S; Tada M; Todo S; Nakagawara A
Oncogene; 2001 Jun; 20(27):3568-72. PubMed ID: 11429704
[TBL] [Abstract][Full Text] [Related]
8. HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter.
Stros M; Ozaki T; Bacikova A; Kageyama H; Nakagawara A
J Biol Chem; 2002 Mar; 277(9):7157-64. PubMed ID: 11748232
[TBL] [Abstract][Full Text] [Related]
9. Deletion of the COOH-terminal region of p73alpha enhances both its transactivation function and DNA-binding activity but inhibits induction of apoptosis in mammalian cells.
Ozaki T; Naka M; Takada N; Tada M; Sakiyama S; Nakagawara A
Cancer Res; 1999 Dec; 59(23):5902-7. PubMed ID: 10606232
[TBL] [Abstract][Full Text] [Related]
10. p21B, a variant of p21(Waf1/Cip1), is induced by the p53 family.
Nozell S; Chen X
Oncogene; 2002 Feb; 21(8):1285-94. PubMed ID: 11850848
[TBL] [Abstract][Full Text] [Related]
11. p73 function is inhibited by tumor-derived p53 mutants in mammalian cells.
Di Como CJ; Gaiddon C; Prives C
Mol Cell Biol; 1999 Feb; 19(2):1438-49. PubMed ID: 9891077
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the p53 homolog p73 by adenoviral oncogene E1A.
Das S; El-Deiry WS; Somasundaram K
J Biol Chem; 2003 May; 278(20):18313-20. PubMed ID: 12639967
[TBL] [Abstract][Full Text] [Related]
13. Physical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expression.
Uramoto H; Izumi H; Nagatani G; Ohmori H; Nagasue N; Ise T; Yoshida T; Yasumoto K; Kohno K
Biochem J; 2003 Apr; 371(Pt 2):301-10. PubMed ID: 12534345
[TBL] [Abstract][Full Text] [Related]
14. p73 transcriptional activity increases upon cooperation between its spliced forms.
Alarcon-Vargas D; Fuchs SY; Deb S; Ronai Z
Oncogene; 2000 Feb; 19(6):831-5. PubMed ID: 10698502
[TBL] [Abstract][Full Text] [Related]
15. Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53.
Fillippovich I; Sorokina N; Gatei M; Haupt Y; Hobson K; Moallem E; Spring K; Mould M; McGuckin MA; Lavin MF; Khanna KK
Oncogene; 2001 Jan; 20(4):514-22. PubMed ID: 11313982
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of transcription and induction of programmed cell death by human p53-family members p63 and p73.
Dietz S; Rother K; Bamberger C; Schmale H; Mössner J; Engeland K
FEBS Lett; 2002 Aug; 525(1-3):93-9. PubMed ID: 12163168
[TBL] [Abstract][Full Text] [Related]
17. p73beta, a variant of p73, enhances Wnt/beta-catenin signaling in Saos-2 cells.
Ueda Y; Hijikata M; Takagi S; Takada R; Takada S; Chiba T; Shimotohno K
Biochem Biophys Res Commun; 2001 May; 283(2):327-33. PubMed ID: 11327702
[TBL] [Abstract][Full Text] [Related]
18. Physical interaction between Wilms tumor 1 and p73 proteins modulates their functions.
Scharnhorst V; Dekker P; van der Eb AJ; Jochemsen AG
J Biol Chem; 2000 Apr; 275(14):10202-11. PubMed ID: 10744705
[TBL] [Abstract][Full Text] [Related]
19. Induction of p73beta by a naphthoquinone analog is mediated by E2F-1 and triggers apoptosis in HeLa cells.
Kang KH; Lee JH; Kim KC; Ham SW; Kim MY; Choi KH
FEBS Lett; 2002 Jul; 522(1-3):161-7. PubMed ID: 12095638
[TBL] [Abstract][Full Text] [Related]
20. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins.
Park JS; Kim EJ; Lee JY; Sin HS; Namkoong SE; Um SJ
Int J Cancer; 2001 Mar; 91(6):822-7. PubMed ID: 11275986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
